Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity.
This report contains market size and forecasts of Pacritinib in global, including the following market information:
Global Pacritinib Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pacritinib Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pacritinib companies in 2021 (%)
The global Pacritinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pacritinib include Adooq Bioscience, Cayman Chemical, APExBIO Technology, BioVision, BOC Sciences, MyBiosource, TargetMol, Selleck Chemicals and AbMole, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pacritinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pacritinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pacritinib Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Pacritinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pacritinib Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Pacritinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pacritinib Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pacritinib revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pacritinib revenues share in global market, 2021 (%)
Key companies Pacritinib sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pacritinib sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adooq Bioscience
Cayman Chemical
APExBIO Technology
BioVision
BOC Sciences
MyBiosource
TargetMol
Selleck Chemicals
AbMole
United States Biological
MuseChem
Clearsynth
Biorbyt
Toronto Research Chemicals
Beyotime